Applicant, as named in the Orange Book

Ibsa Inst Bio

Next listed expiry: Licart on 20 Feb 2035. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Licart diclofenac epolamine	diclofenac epolamine	206976	20 Feb 2035	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.